Clinical Trial Update: Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for JSKN016 combination therapy in inoperable locally advanced or metastatic HER2-negative breast cancer, spanning Phase 1 and Phase 2, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inoperable Locally Advanced Breast Cancer

Drugs mentioned

• JSKN016

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Inoperable Locally Advanced HER2-Negative Breast Cancer, Metastatic HER2-Negative Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING